Impact of Comorbidity on Ovarian Cancer Mortality
Author Information
Author(s): Tetsche Mette S, Dethlefsen Claus, Pedersen Lars, Sorensen Henrik T, Norgaard Mette
Primary Institution: Aarhus University Hospital
Hypothesis
Poorer survival among ovarian cancer patients with severe comorbidity may be explained by a higher prevalence of advanced cancer at diagnosis.
Conclusion
The presence of severe comorbidity was associated with an advanced stage of ovarian cancer, leading to higher mortality rates.
Supporting Evidence
- Comorbidity was more common among patients with advanced cancer stages.
- One- and five-year survival rates were higher in patients without comorbidity.
- The impact of severe comorbidity on mortality varied by cancer stage.
Takeaway
Having other serious health problems makes it harder for women with ovarian cancer to survive, especially if their cancer is more advanced.
Methodology
The study analyzed data from the Danish Cancer Registry and the Danish National Hospital Discharge Registry for patients diagnosed with ovarian cancer from 1995 to 2003.
Potential Biases
Possible inaccuracies in treatment data and comorbidity classification.
Limitations
Potential misclassification of cancer stage and comorbidity due to reliance on registry data.
Participant Demographics
Patients aged over 15 years diagnosed with ovarian cancer, median age 62 years.
Statistical Information
Confidence Interval
95% CI provided for various mortality rate ratios.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website